The different influence of obesity on ER+ breast cancer development, depending on menopausal status, is explained by hormonal changes, in terms of circulating estrogen, before and after menopause [111, 112]. This evidence concerns the gene ESR1 and obesity due to melanocortin 4 receptor deficiency.